Headache & Migraine
Conference Coverage
Drugs to prevent versus those to treat migraine might not share targets
The distinct molecular events in each phase of migraine suggest the prevention and treatment targets differ.
Conference Coverage
Adolescents with migraine need smooth handoff to adult care
One goal of migraine management in adolescents and young adults should be to prevent adulthood chronicity.
Expert Perspective
Switching Patients From a Triptan to a Gepant for Acute Migraine Care and Effective Preventives
Conference Coverage
Avoid adding to minority stress when treating headache in LGBTQIA+ patients
To address headache in LBGTQIA+ patients, inclusive behavior can set the stage of collaboration toward control.
News
Are migraine preventives underused in young adults?
While researchers suggest their findings could show underuse of preventive migraine medications in young adults, an expert notes the reality is...
Expert Perspective
Biofeedback Training Is a Good Alternative to Preventive Medication for Migraine and Tension-Type Headache
Conference Coverage
What is the proper treatment for posttraumatic headache? Expert debate
Preventative treatment could reduce chronification, but has the potential to worsen comorbidities.
Conference Coverage
Prodrome treatment with ubrogepant prevents migraines
Intervention also reduced prodromal symptoms in patients who could reliably predict oncoming headaches.
Conference Coverage
Migraine treatment with rimegepant linked to reduced barbiturate use
Real-world analysis suggests potential for improvements in medication overuse and dependency.
Conference Coverage
Anti-CGRP monoclonal antibody offers relief from migraine and comorbid depression
“If the patient has migraine and depression and you treat with fremanezumab, both disorders get better to a statistically significant degree.”